Cargando…
Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia.
The purpose of this study is to determine the efficacy of low dose cytosine arabinoside (LD Ara-C) as an alternative treatment to conventional cytotoxic induction chemotherapy in childhood acute promyelocytic leukemia (APL). Four children with APL in poor medical condition prior to chemotherapy were...
Autores principales: | Sung, K. W., Choi, H. S., Yoo, E. S., Rhu, K. H., Shin, H. Y., Ahn, H. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054219/ https://www.ncbi.nlm.nih.gov/pubmed/9288628 |
Ejemplares similares
-
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011) -
High-dose cytosine arabinoside (Ara-C) in colorectal cancer.
por: Kanojia, M., et al.
Publicado: (1983) -
A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979) -
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
por: Rohatiner, A. Z., et al.
Publicado: (1990) -
Enhancement of the Cytotoxicity of Cytosine Arabinoside by Interleukin‐3
por: Tanaka, Masao
Publicado: (1992)